ArriVent BioPharma, Inc. (NASDAQ:AVBP)

US · Delayed Price · Currency is USD

Healthcare · Biotechnology

Full ChartAlerts Compare

13.35-1.52 (-10.22%)

Market cap

$658M

Insider Score

Not scored

Health Score

54 Fair

Analyst consensus

Buy

Listed since

Jan 26, 2024

Website

arrivent.com

Insider Score

––Not scored

AVBP Insider Score

Insiders here have filed 5 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.

See stocks that are scored

AVBP Stock Insider Trading Activity

AVBP stock’s insider trading shows no open-market insider trades by company insiders over the last 6 months.

Not enough price history.

Insider Trading Activity (Form 4 Filings)

An insider trade occurs when an individual that has non-public information about a company buys or sells shares of that company’s stock. Examples of insiders include a company’s executive officers (CEO, CFO, COO), its board of directors, and its major shareholders. Insiders are required to submit their trading activity to the SEC through Form 4 filings.

Insider	Action	Shares	Avg Cost	Total	Δ Holdings	Held After	Date	Grade	Form 4
LaChapelle Robin COO	Option exercise	16,265	$3.65	$59.37K	12.0%	152,001	Oct 30, 2026	—	Form 4
LaChapelle Robin COO	Option exercise	410	$2.28	$935.42	0.3%	152,411	Oct 30, 2026	—	Form 4
LaChapelle Robin COO	Option exercise	4,550	$2.28	$10.38K	3.0%	156,961	Oct 30, 2026	—	Form 4
LaChapelle Robin COO	Option exercise	1,820	$2.28	$4.15K	1.2%	158,781	Oct 30, 2026	—	Form 4
LaChapelle Robin COO	Option exercise	17,648	$6.24	$110.05K	11.1%	176,429	Oct 30, 2026	—	Form 4

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.